In summary, this study uncovers LILRB4's dual role in female PD patients: its variants may delay motor symptom progression by preserving DAT function but exacerbate cognitive deficits, underscoring the complexity of sex‐specific pathological mechanisms. The gene discussed is SLC6A3; the disease is Cognitive impairment.